Atlantic Trust LLC acquired a new stake in Thermo Fisher Scientific Inc (NYSE:TMO) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 790 shares of the medical research company’s stock, valued at approximately $138,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Amalgamated Bank raised its position in Thermo Fisher Scientific by 57.0% in the 2nd quarter. Amalgamated Bank now owns 44,921 shares of the medical research company’s stock valued at $7,837,000 after purchasing an additional 16,308 shares during the last quarter. BB&T Securities LLC raised its position in shares of Thermo Fisher Scientific by 4.4% during the first quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock worth $13,798,000 after acquiring an additional 3,819 shares during the last quarter. Mutual of America Capital Management LLC raised its position in shares of Thermo Fisher Scientific by 2.1% during the second quarter. Mutual of America Capital Management LLC now owns 47,728 shares of the medical research company’s stock worth $8,327,000 after acquiring an additional 977 shares during the last quarter. Mitchell Capital Management Co. raised its position in shares of Thermo Fisher Scientific by 40.3% during the second quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock worth $7,841,000 after acquiring an additional 12,910 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System raised its position in shares of Thermo Fisher Scientific by 0.9% during the second quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock worth $101,317,000 after acquiring an additional 5,213 shares during the last quarter. Hedge funds and other institutional investors own 83.66% of the company’s stock.

TMO has been the subject of a number of recent research reports. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $214.00 target price for the company in a research report on Thursday, September 14th. Bank of America Corporation reaffirmed a “buy” rating and set a $210.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Friday, July 21st. Cleveland Research raised Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research note on Thursday, July 20th. Cowen and Company reaffirmed a “buy” rating and set a $200.00 price objective on shares of Thermo Fisher Scientific in a research note on Friday, September 1st. Finally, Argus reaffirmed a “buy” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, August 22nd. They noted that the move was a valuation call. One equities research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $205.71.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at $186.18 on Friday. Thermo Fisher Scientific Inc has a twelve month low of $139.07 and a twelve month high of $201.20. The stock has a market capitalization of $74,657.24, a PE ratio of 20.46, a P/E/G ratio of 1.71 and a beta of 1.08. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The business had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the prior year, the company posted $2.03 earnings per share. Thermo Fisher Scientific’s revenue was up 13.9% on a year-over-year basis. analysts expect that Thermo Fisher Scientific Inc will post 9.36 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be issued a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.60 annualized dividend and a yield of 0.32%. Thermo Fisher Scientific’s payout ratio is presently 10.19%.

In other Thermo Fisher Scientific news, VP Peter E. Hornstra sold 3,894 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total value of $721,090.92. Following the sale, the vice president now owns 19,751 shares in the company, valued at $3,657,490.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jim P. Manzi sold 1,000 shares of the company’s stock in a transaction that occurred on Thursday, August 17th. The shares were sold at an average price of $175.20, for a total value of $175,200.00. Following the completion of the sale, the director now owns 38,757 shares in the company, valued at approximately $6,790,226.40. The disclosure for this sale can be found here. Insiders have sold 22,738 shares of company stock worth $4,021,512 in the last quarter. 0.49% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “Atlantic Trust LLC Acquires Shares of 790 Thermo Fisher Scientific Inc (TMO)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another site, it was copied illegally and reposted in violation of U.S. & international copyright laws. The correct version of this article can be accessed at https://www.watchlistnews.com/atlantic-trust-llc-acquires-shares-of-790-thermo-fisher-scientific-inc-tmo/1697679.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.